指南与共识消化与肝胆胰病理

基于图像的细胞外黏液-肿瘤面积比预测结直肠癌共识分子亚型

Image-based assessment of extracellular mucin-to-tumor area predicts consensus molecular subtypes (CMS) in colorectal cancer.
指南 / 共识 · Mod Pathol · 2021-09-02

研究开发弱监督分割算法量化H&E图像中细胞外黏液-肿瘤面积比,与病理学家评分高度一致(ICC=0.92),并应用于TCGA和Bern队列。TCGA中黏液性肿瘤主要富集于CMS1(25.7%)、CMS3(24.6%)和CMS4(16.2%),CMS2平均黏液仅1.8%;MUC5AC蛋白表达与侵袭性特征和不良生存相关,MUC2则与较少脉管侵犯相关。

要点

  • 深度学习算法可准确量化结直肠癌H&E图像中细胞外黏液面积。
  • CMS2亚型黏液极少,MUC2/MUC4/MUC5AC/MUC5B表达低至缺失。
  • MUC5AC蛋白表达与BRAF突变、MSI和不良生存相关。

核心结论

  • 细胞外黏液-肿瘤面积比与CMS分型相关,CMS2中黏液极少且黏液蛋白表达低至缺失。
  • MUC5AC蛋白表达与侵袭性特征和不良5年总生存相关,MUC2表达则与较少淋巴和静脉侵犯相关。

研究设计与样本

  • 开发弱监督分割方法量化H&E图像中细胞外黏液-肿瘤面积比,并与两位病理学家评分比较(ICC=0.92)。
  • 应用于TCGA队列(871张切片/412例患者)分析黏液与CMS分组相关性,以及Bern队列(775张切片/517例患者)进行组织病理学关联和TMA构建。
  • 利用TCGA和CPTAC(85例患者)通过基因和蛋白表达分析验证MUC2、MUC4、MUC5AC和MUC5B的黏液检测和CMS分类。

主要发现

  • TCGA中黏液性肿瘤主要分布于CMS1(25.7%)、CMS3(24.6%)和CMS4(16.2%),CMS2平均黏液为1.8%。
  • RNA和蛋白表达显示MUC2、MUC4、MUC5AC和MUC5B在CMS2中低至缺失。
  • MUC5AC蛋白表达与远处转移(p=0.0334)、BRAF突变(p<0.0001)、错配修复缺陷(p<0.0001)和不良5年总生存(阳性 vs 阴性:44% vs 65%)相关。
  • MUC2表达与较少淋巴管侵犯(p=0.0096)和静脉侵犯(p=0.0023)相关,对生存无影响。

关键数值与推荐

  • 黏液性组织学通常定义为细胞外黏液-肿瘤面积比>50%。
  • 算法与病理学家评分组内相关系数ICC=0.92。
  • CMS2平均黏液面积比为1.8%。
  • MUC5AC阳性与阴性5年总生存率分别为44%和65%。

临床怎么用

  • 基于H&E图像的黏液面积量化可辅助预测结直肠癌CMS分型,尤其识别CMS2(黏液极少)。
  • 结合MSI状态和组织学黏液特征可能仅通过病理图像预测CMS分类,应纳入未来分子亚型图像分类器。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The backbone of all colorectal cancer classifications including the consensus molecular subtypes (CMS) highlights microsatellite instability (MSI) as a key molecular pathway. Although mucinous histology (generally defined as >50% extracellular mucin-to-tumor area) is a "typical" feature of MSI, it is not limited to this subgroup. Here, we investigate the association of CMS classification and mucin-to-tumor area quantified using a deep learning algorithm, and the expression of specific mucins in predicting CMS groups and clinical outcome. A weakly supervised segmentation method was developed to quantify extracellular mucin-to-tumor area in H&E images. Performance was compared to two pathologists' scores, then applied to two cohorts: (1) TCGA (n = 871 slides/412 patients) used for mucin-CMS group correlation and (2) Bern (n = 775 slides/517 patients) for histopathological correlations and next-generation Tissue Microarray construction. TCGA and CPTAC (n = 85 patients) were used to further validate mucin detection and CMS classification by gene and protein expression analysis for MUC2, MUC4, MUC5AC and MUC5B. An excellent inter-observer agreement between pathologists' scores and the algorithm was obtained (ICC = 0.92). In TCGA, mucinous tumors were predominantly CMS1 (25.7%), CMS3 (24.6%) and CMS4 (16.2%). Average mucin in CMS2 was 1.8%, indicating negligible amounts. RNA and protein expression of MUC2, MUC4, MUC5AC and MUC5B were low-to-absent in CMS2. MUC5AC protein expression correlated with aggressive tumor features (e.g., distant metastases (p = 0.0334), BRAF mutation (p < 0.0001), mismatch repair-deficiency (p < 0.0001), and unfavorable 5-year overall survival (44% versus 65% for positive/negative staining). MUC2 expression showed the opposite trend, correlating with less lymphatic (p = 0.0096) and venous vessel invasion (p = 0.0023), no impact on survival.The absence of mucin-expressing tumors in CMS2 provides an important phenotype-genotype correlation. Together with MSI, mucinous histology may help predict CMS classification using only histopathology and should be considered in future image classifiers of molecular subtypes.

来源:Mod Pathol,查看原文。版权归原作者所有。

引用

  1. Nguyen HG, Lundström O, Blank A, et al. Image-based assessment of extracellular mucin-to-tumor area predicts consensus molecular subtypes (CMS) in colorectal cancer. Mod Pathol. 2021. PMID: 34475526. doi:10.1038/s41379-021-00894-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。